对P2X4受体的全抑制的结构性见解
Cheng Shen1, Yuqing Zhang2, Wenwen Cui2
1State Key Laboratory of Genetic Engineering, Shanghai Key Laboratory of Bioactive Small Molecules, Collaborative Innovation Center of Genetics and Development, Department of Physiology and Neurobiology, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Nature communications
|October 13, 2023
概括
研究人员确定了P2X4受体的冷EM结构与对抗剂BX430和BAY-1797. 这些发现揭示了全抑制剂如何与P2X4通道结合,为神经病痛药物开发提供了洞察力.
科学领域:
- 结构生物学是结构生物学.
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
背景情况:
- P2X受体是ATP导入的离子通道,对于细胞信号传输至关重要.
- P2X4受体亚型与免疫反应和中枢神经系统功能有关,特别是神经病痛.
- P2X4受体正在成为疼痛管理的重要治疗点.
研究的目的:
- 阐明P2X4受体的全抑制的结构基础.
- 描述P2X4亚型特异性抗体BX430和BAY-1797.7的结合相互作用.
- 提供对P2X4受体功能和全调节的机制性见解.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定高分辨率结构.
- 基于结构的突变分析与电生理学相结合.
- 用不同的配体和其他P2X亚型对P2X4受体复合物的比较结构分析.
主要成果:
- 冷-EM结构显示,抗体BX430和BAY-1797与细胞外域的子单元接口上的一个共同的全位结合.
- 电生理学研究确定了在斑马鱼和人类P2X4受体中负责全抑制的关键残留物.
- 干结合诱导了全囊中的重组,稳定了结合的对抗体,并防止了与通道激活相关的构造变化.
结论:
- 该研究提供了详细的结构洞察力,了解特定抗剂对P2X4受体的全抑制机制.
- 鉴定关键残留物和结合点有助于设计用于神经病痛的新型P2X4向治疗方法.
- 了解亚型特定的全抑制机制可以指导开发更有选择性的药物.
更多相关视频
相关概念视频
Allosteric Regulation
58.1K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


